The authors reply
Crit Care Med
.
2025 Jun 1;53(6):e1346-e1347.
doi: 10.1097/CCM.0000000000006675.
Epub 2025 Jun 3.
Authors
Asad E Patanwala
1
2
,
Xuya Xiao
3
4
,
Thomas E Hills
5
,
Alisa M Higgins
6
,
Colin J McArthur
7
,
G Caleb Alexander
3
4
8
,
Hemalkumar B Mehta
3
4
;
National Covid Cohort Collaborative (N3C) Consortium
Affiliations
1
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
2
Department of Pharmacy, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
3
Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
4
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
5
Medical Research Institute of New Zealand, Wellington, New Zealand.
6
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
7
Auckland City Hospital, Auckland, New Zealand.
8
Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD.
PMID:
40459396
DOI:
10.1097/CCM.0000000000006675
No abstract available